CIA
GSK icon

Concurrent Investment Advisors’s GSK GSK Stock Holding History

Concurrent Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$911K Sell
16,515
-1,522
-8% -$82.5K 0.01% 912
2025
Q4 		$885K Sell
18,037
-2,907
-14% -$136K 0.01% 888
2025
Q3 		$904K Buy
20,944
+246
+1% +$9.61K 0.02% 684
2025
Q2 		$795K Buy
20,698
+3,841
+23% +$147K 0.02% 675
2025
Q1 		$653K Buy
16,857
+3,719
+28% +$136K 0.02% 665
2024
Q4 		$444K Sell
13,138
-5,831
-31% -$210K 0.01% 703
2024
Q3 		$775K Buy
18,969
+7,080
+60% +$290K 0.02% 525
2024
Q2 		$458K Buy
11,889
+1,663
+16% +$70K 0.02% 614
2024
Q1 		$438K Sell
10,226
-140
-1% -$5.77K 0.02% 583
2023
Q4 		$384K Buy
+10,366
New +$372K 0.02% 562

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Concurrent Investment Advisors's GSK Position: Q1 2026 in Review

Concurrent Investment Advisors reduced its GSK (GSK) stake by 8.4% in Q1 2026, selling an estimated $82.5K and leaving 16,515 shares worth $911K. The position accounts for 0.01% of the portfolio, ranked #912.

Concurrent Investment Advisors first reported a position in GSK in Q4 2023 and has held it in 10 quarters since. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Concurrent Investment Advisors held 16,515 shares of GSK worth $911K as of Q1 2026.
  • Concurrent Investment Advisors sold 1,522 GSK shares in Q1 2026, an estimated $82.5K.
  • GSK made up 0.01% of Concurrent Investment Advisors's portfolio in Q1 2026, its #912 holding.
  • Concurrent Investment Advisors first reported a position in GSK in Q4 2023 and has held it in 10 quarters since.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.